Gemini Space Station, Inc. [GEMI] Securities Class Action Lawsuit Update

• Case Name: Methvin v. Gemini Space Station, Inc., et al.
• Case No.: 1:26-cv-02261
• Jurisdiction: U.S. District Court, Southern District of New York
• Filed on: March 18, 2026
• Class Period: September 12, 2025 - February 17, 2026

Introduction

Gemini Space Station, Inc. entered the public markets in September 2025 as a crypto-platform growth story built on expanding monthly transacting users, deepening trading volume, and widening its international footprint. Investors now allege that story was already fraying. According to the complaint, Gemini’s IPO documents and post-IPO statements painted a company committed to its “core exchange product” and international expansion, while omitting the alleged non-speculative risk that the business was heading toward an expensive restructuring and strategic retreat.

The alleged corrective truth arrived in stages. First came the February 5, 2026 “Gemini 2.0” announcement: a prediction-market-first pivot, a 25% workforce reduction, and exits from the U.K., E.U., and Australia. Then came the February 17 disclosure of executive departures, worsening expense estimates, and a deeper leadership reset. Together, those disclosures allegedly erased much of the market’s confidence in the GEMI IPO narrative.

“Most GEMI shareholders never file or join the class action, which means they miss out on potential recovery funds,” said Attorney Joseph Levi.

Backdrop and Business Context

Gemini was founded in 2014 as a cryptocurrency trading and custody platform. The complaint emphasizes that its IPO materials repeatedly described the exchange as Gemini’s “core” product, with transaction fees driving the majority of revenue. The registration statement highlighted approximately 549,000 monthly transacting users, over 10,000 institutions, more than $21 billion in assets on platform, and more than $285 billion in lifetime trading volume as of July 31, 2025.

The September 2025 IPO priced 15,178,572 Class A shares at $28 per share, raising roughly $398.4 million before expenses. The offering story leaned heavily on MTU growth, retail acquisition, institutional penetration, and international licensing in Europe and APAC. That matters because the later restructuring allegedly reversed each of those pillars in one stroke.

Promises Made vs. Reality

The complaint quotes Gemini’s offering materials as saying the company was “predominantly focused on expanding [its] exchange platform via increased MTUs, increased average daily trading volume, and increasing the number of assets available.” It also described Europe and APAC as foundational to sustained growth.

Yet plaintiffs allege those statements omitted that Gemini had already overstated the durability of its crypto-platform model and the viability of its international expansion strategy. The offering documents mentioned prediction markets only briefly, and event contracts appeared as just one of several product initiatives. Nothing in the complaint alleges the IPO materials signaled a near-term wholesale corporate pivot into a prediction-market-centric company.

That contrast drives the theory of falsity: investors say the public narrative promised expansion and diversification, while internal realities allegedly pointed toward contraction, restructuring costs, and executive turnover.

Timeline of Alleged Misconduct and Disclosures

The alleged misconduct begins at the IPO on September 12, 2025, when GEMI began trading on Nasdaq at $28 per share. On November 10, 2025, executives reinforced the international growth story on the Q3 earnings call. Cameron Winklevoss described launches in Australia and a MiCA license in Europe as proof of “the strength of our model.” CFO Dan Chen told investors Gemini still expected MTUs to grow at a 20% to 25% compound rate over the medium term.

Then the narrative broke. On February 5, 2026, Gemini disclosed “Gemini 2.0,” stating that prediction markets would become “more front-and-center,” that 25% of the workforce would be cut, and that the company would exit the U.K., E.U., and Australian markets. Shares fell 8.72% to $6.70. Twelve days later, on February 17, Gemini disclosed the departures of the CFO, COO, and chief legal officer, while estimating $520 million to $530 million in operating expenses, up approximately 40% year over year. Shares fell another 12.9% to $6.585.

The chronology alleged in the complaint is: growth narrative, sudden pivot, executive exits, and analyst commentary raising concern about the company’s financial profile.

Investor Harm and Market Reaction

The market reaction was immediate and cumulative. From the $28 IPO price to the $6.585 close following the February 17 disclosure, GEMI lost roughly 76% of its value.

The complaint ties that destruction to specific disclosures, the February 5 pivot and layoffs (-8.72%) and the February 17 leadership exits and expense warning (-12.9%).

Analysts reacted in parallel. According to the complaint, Evercore ISI downgraded the stock from outperform to in line and cut its price target from $15 to $10 after the February 5 disclosure. Truist Securities later downgraded GEMI from buy to hold and cut its target from $13 to $7, citing expense concerns and leadership turnover. Needham & Co. and Rosenblatt Securities also sharply reduced targets.

This is where loss causation becomes especially clear in the pleading: each step of the alleged truth emergence corresponded to a discrete repricing event.

Litigation and Procedural Posture

The complaint pleads four principal counts: Section 10(b) and Rule 10b-5; Section 20(a); Section 11; and Section 15.

Scienter allegations focus heavily on insider knowledge of the company’s strategic instability and one notable stock sale: former COO Marshall Beard allegedly sold 479,901 shares for approximately $11.8 million during the class period. Plaintiffs cite this as motive evidence. The complaint also invokes Item 105 of Regulation S-K, alleging Gemini failed to disclose the true magnitude of the risk that its stated revenue-growth strategies could fail and force a disruptive restructuring.

Procedurally, the case is at the complaint stage. No class has been certified, and no merits rulings have been made.

Shareholder Sentiment

Public retail commentary reflected a mixed but volatile reaction. On Reddit, discussion around GEMI focused on profitability concerns at the time of the IPO and, later, on the abrupt post-IPO leadership shakeup and layoffs. On Stocktwits, public discussion increased around the February 17 disclosure. Taken conservatively, the public retail discussion appears best characterized as active, skeptical, and event-driven rather than uniformly negative.

Analyst Commentary

Professional analyst reaction is unusually well-developed in the complaint.

Evercore ISI’s post-pivot downgrade framed “Gemini 2.0” as potentially beneficial over time but mismatched with what investors wanted from an early-stage public company: growth.

Truist’s later downgrade was sharper, pointing directly to the deeper-than-expected loss profile, executive turnover, and the risk that investors would begin questioning Gemini’s solvency. Needham and Rosenblatt followed with material price target reductions tied to what they described as major restructuring and management disruption.

For securities plaintiffs, these third-party reactions strengthen the alleged connection between disclosure content and market harm.

SEC Filings & Risk Factors

The SEC filing trail is central to this case:

• August 15, 2025: S-1 filed
• September 15, 2025: final prospectus on Form 424B4
• November 10, 2025: Form 10-Q and earnings call
• February 5, 2026: Form 8-K with “Gemini 2.0”
• February 17, 2026: Form 8-K with executive departures and preliminary FY2025 estimates

The key risk-factor allegation is omission. Plaintiffs say the offering materials warned that international expansion timing was uncertain, but never disclosed the allegedly concrete risk that the company could soon abandon those markets altogether, cut staff, and incur substantial severance and compensation obligations tied to departing executives.

That alleged omission is what transforms ordinary business risk into a Section 11 and Item 105 theory.

Conclusion: Implications for Investors

The GEMI securities class action is, at its core, about strategic continuity. Investors allege they bought a crypto exchange platform with a global growth roadmap and instead received a rapid transformation into a prediction-market-first company carrying restructuring costs, executive exits, and shrinking international reach.

For investors, the red flags alleged here are familiar: post-IPO narrative reversal, leadership instability, elevated expense expectations, and strategic pivots that allegedly conflicted with the core thesis presented in the offering materials. In the crypto and fintech sectors especially, where business models can evolve quickly, the legal question is whether that evolution was truly new—or already knowable when the shares were sold.

Now, investors are fighting back.

How to Join the Gemini Space Station (GEMI) Class Action

• Confirm you purchased GEMI shares during the September 12, 2025 to February 17, 2026 period, or in the IPO
• Review eligibility details in the filed complaint and class definition
• Click here to check eligibility

Disclaimer: This shareholder alert is for informational purposes only and does not constitute legal advice. Consult a qualified attorney for personalized guidance. No specific outcomes are guaranteed.